Tevogen Inc. Share Price
NASDAQ: TVGN | Micro CapTevogen Inc. Stock Performance
Tevogen Inc. Share Price Today
As of 18 September 2026, Tevogen Inc.'s share price is $7.70. The stock opened at $7.70, compared to its previous close of $7.51. During today's trading session, Tevogen Inc.'s share price traded between $7.70 and $7.70, with an average price of $7.70. Over the past 52 weeks, the stock has recorded a high of $11.85 and a low of $0.15. In terms of performance, Tevogen Inc.'s share price has risen by 71.49% over the last six months and is up 882.14% on a year-on-year basis.
Tevogen Inc. Share Price Chart
Tevogen Inc. Quarterly Profit & Loss
All figures in USD
Tevogen Inc. Annual Profit & Loss
All figures in USD
About Tevogen Inc.
Tevogen Bio Holdings Inc., a clinical-stage specialty immunotherapy company, develops off-the-shelf precision T cell therapies for the treatment of infectious diseases, cancers, and other disorders. The company develops TVGN 489, which has completed Phase 1 clinical trial for the treatment of ambulatory high-risk adult COVID-19 patients. It is also developing TVGN 920 for treating cervical cancer; TVGN 960 for treating oropharyngeal cancer; TVGN 601 for treating MS; and TVGN 930 for treating EBV-associated lymphomas. Tevogen Bio Holdings Inc. was formerly known as Tevogen Bio Inc. and changed its name to Tevogen Bio Holdings Inc. in February 2024. The company was founded in 2020 and is headquartered in Warren, New Jersey.
Tevogen Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Sep 2026 | $7.21 | $7.70 | +22.03% |
Aug 2026 | $7.29 | $6.31 | -3.81% |
Jul 2026 | $6.29 | $6.56 | +13.10% |
Jun 2026 | $7.87 | $5.80 | -27.59% |
May 2026 | $7.04 | $8.01 | +17.36% |
Apr 2026 | $4.49 | $6.83 | +52.00% |
Mar 2026 | $0.25 | $4.49 | +1,594.34% |
Feb 2026 | $0.28 | $0.27 | -11.37% |
Jan 2026 | $0.33 | $0.30 | -9.94% |
Dec 2025 | $0.45 | $0.33 | -24.55% |
Nov 2025 | $0.63 | $0.44 | -29.15% |
Oct 2025 | $0.78 | $0.62 | -20.79% |